Announcement

19 May 2022

Earlier this year we welcomed Laura Danielson, Children and Young People’s Research Lead to the ECMC team. Laura takes over from Sheona Scales who is currently on secondment in the CRUK Cancer Grand Challenge team. Find out more about Laura.

24 Feb 2022

The ECMC Network Strategy was approved by the ECMC funders at the end of 2022. The Strategy has been developed in partnership with members of the ECMC network and stakeholders including industry, regulators and ECMC funders.

24 Feb 2022

Over the past year the ECMC Research Nurse Network Group has delivered training for more than 40 research nurses new to working in early phase cancer research. The aim of this training is to equip new early phase research nurses to deliver high quality, patient-centred care within the regulatory framework. The ECMC has run this training at various locations across the UK five times. We recognised the importance of ensuring that new research nurses continued to have the opportunity to access this training. The one-day in person training was updated to become two half-day online sessions.

30 Nov 2021

Preliminary applications are invited for new sites to join the adult ECMC network. Please note that existing ECMCs do not need to submit a preliminary application. ECMC awards provide infrastructure funding to support experimental cancer medicine activity in sites across the UK. Bids must be submitted as a joint applications from at least one NHS Trust/Health Board organisation and one university partner.

28 Apr 2021

Based on experiences and approaches from across the ECMC network the Centre Business Leads worked collaboratively to produce guidance on what to consider when reviewing and making improvements to local restart frameworks to set up, open and recruit to trials during national emergencies. This document can be used by members of the network to help implement or improve restart prioritisation categorisation of trials.

24 Feb 2021

At the beginning of 2020, the COVID-19 Pandemic resulted in restrictions which made on-site monitoring of clinical trial data and documents more challenging due to safety and social distancing restrictions. These restrictions meant alternative ways of monitoring clinical trials needed to be explored and implemented to ensure data integrity and patient safety on clinical trials.

24 Feb 2021

ECMC Quinquennial Review 12-month delay

The ECMC Network quinquennial review process has been delayed for 12-months, due to the impact of the pandemic on the ECMC Network sites. 

The current 5- year ECMC funding period (2017 – 2022) is due to end in March 2022. A quinquennial review process was scheduled to run between March and October this year to award funding for the 4th ECMC quinquennium (2022 – 2027). However, all sites in the network have been seriously impacted by the current wave of the Covid-19 pandemic.  

09 Dec 2020

Read recent updates from the Advanced & Cell Therapies team led by Professor Fiona Thistlethwaite and about the recent appointment of Dr Emma Searle to the Haematology team within the Manchester ECMC

Pages